BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16507779)

  • 1. Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma.
    Little RF; Pluda JM; Wyvill KM; Rodriguez-Chavez IR; Tosato G; Catanzaro AT; Steinberg SM; Yarchoan R
    Blood; 2006 Jun; 107(12):4650-7. PubMed ID: 16507779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma.
    Little RF; Aleman K; Kumar P; Wyvill KM; Pluda JM; Read-Connole E; Wang V; Pittaluga S; Catanzaro AT; Steinberg SM; Yarchoan R
    Blood; 2007 Dec; 110(13):4165-71. PubMed ID: 17846226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma.
    Tulpule A; Joshi B; DeGuzman N; Espina BM; Mocharnuk R; Prakash O; Templeton D; Levine AM; Gill PS
    Ann Oncol; 1997 Jan; 8(1):79-83. PubMed ID: 9093711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
    Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
    J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial.
    Krown SE; Lee JY; Lin L; Fischl MA; Ambinder R; Von Roenn JH
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):149-53. PubMed ID: 16394845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
    Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
    Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
    Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial.
    Aboulafia DM; Norris D; Henry D; Grossman RJ; Thommes J; Bundow D; Yocum RC; Stevens V
    Arch Dermatol; 2003 Feb; 139(2):178-86. PubMed ID: 12588223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
    Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
    Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
    J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of IL-6, IL-10 and CXCL10 serum concentrations with visceral Kaposi's sarcoma in people living with HIV/AIDS.
    Lopes TRR; Gonçales JP; Silva Júnior JVJ; Lorena VMB; Toscano ALCC; Akamatsu SM; Salles AC; Tozetto-Mendoza TR; Morais VMS; Coêlho MRCD
    Hum Immunol; 2020 Jan; 81(1):26-31. PubMed ID: 31866063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
    Stebbing J; Wildfire A; Portsmouth S; Powles T; Thirlwell C; Hewitt P; Nelson M; Patterson S; Mandalia S; Gotch F; Gazzard BG; Bower M
    Ann Oncol; 2003 Nov; 14(11):1660-6. PubMed ID: 14581275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma.
    Miles SA; Testa M; Huang J; Wade M; Carden J; Scadden DT
    J Interferon Cytokine Res; 2002 Nov; 22(11):1143-8. PubMed ID: 12513914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study.
    Krown SE; Li P; Von Roenn JH; Paredes J; Huang J; Testa MA
    J Interferon Cytokine Res; 2002 Mar; 22(3):295-303. PubMed ID: 12034036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.
    Lane HC; Falloon J; Walker RE; Deyton L; Kovacs JA; Masur H; Banks S; Kirk LE; Baseler MW; Salzman NP
    Ann Intern Med; 1989 Jul; 111(1):41-50. PubMed ID: 2735626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.
    Yarchoan R; Pluda JM; Wyvill KM; Aleman K; Rodriguez-Chavez IR; Tosato G; Catanzaro AT; Steinberg SM; Little RF
    Crit Rev Immunol; 2007; 27(5):401-14. PubMed ID: 18197804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.
    Miles SA; Wang HJ; Cortes E; Carden J; Marcus S; Mitsuyasu RT
    Ann Intern Med; 1990 Apr; 112(8):582-9. PubMed ID: 2109563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.
    Nelson BC; Borok MZ; Mhlanga TO; Makadzange AT; Campbell TB
    Int J Infect Dis; 2013 Oct; 17(10):e902-6. PubMed ID: 23809198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS).
    Kovacs JA; Deyton L; Davey R; Falloon J; Zunich K; Lee D; Metcalf JA; Bigley JW; Sawyer LA; Zoon KC
    Ann Intern Med; 1989 Aug; 111(4):280-7. PubMed ID: 2757312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.